Scholarlink

Introduction <p>Allergic rhinitis is an IgE-mediated disease with a prevalence of 10.48%. Licari et al., (2023) J Allergy Clin Immunol Pract 11(8) 2547–2556, It affects children’s quality of life, from poor academic performance to poor smell and voice. Our aims were to assess and enhance the management of children with allergic rhinitis from primary care to secondary care.</p> Methods <p>This is a two-stage, prospective cross-sectional study utilizing a multidisciplinary team approach. Stage one assessed the management of allergic rhinitis amongst primary and secondary care. The second stage took a human centred approach to review the patient’s pathway within secondary care. These insights were used to develop assessment and educational tools. Questionnaires were distributed to general practitioners (GPs), pharmacists and patients.</p> Results <p>One hundred completed questionnaires were returned (39 GPs, 61 pharmacists). Twenty-six per cent of respondents reported giving the correct advice regarding intranasal corticosteroid sprays (INCS). In secondary care, 106 children were reviewed. Twenty-four parents completed feedback forms, all felt the parent proforma was easy to complete and helpful to their appointment. Clinician feedback was overall positive and found, “The proforma and preformatted prescription improved efficiency and allowed more consultation time to explain the technique and importance of daily use of the steroid nasal spray". In the later stages of this study, discharge rates for new patients were 78.4%.</p> Conclusion <p>This study highlights a team-based, patient centred approach to enhance the assessment and management of children with allergic rhinitis. The team created a standardized means of assessment and developed management algorithms to assist community and hospital care providers.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A multi-faceted, human-centred approach to enhance the assessment and management of children with allergic rhinitis

  • 期刊论文

  • 发表日期：

    2025年11月24日

查看全文
  • Seamus Boyle,
  • Michael Fitzsimons,
  • Eimear Phelan,
  • Colleen Heffernan

摘要

Introduction

Allergic rhinitis is an IgE-mediated disease with a prevalence of 10.48%. Licari et al., (2023) J Allergy Clin Immunol Pract 11(8) 2547–2556, It affects children’s quality of life, from poor academic performance to poor smell and voice. Our aims were to assess and enhance the management of children with allergic rhinitis from primary care to secondary care.

Methods

This is a two-stage, prospective cross-sectional study utilizing a multidisciplinary team approach. Stage one assessed the management of allergic rhinitis amongst primary and secondary care. The second stage took a human centred approach to review the patient’s pathway within secondary care. These insights were used to develop assessment and educational tools. Questionnaires were distributed to general practitioners (GPs), pharmacists and patients.

Results

One hundred completed questionnaires were returned (39 GPs, 61 pharmacists). Twenty-six per cent of respondents reported giving the correct advice regarding intranasal corticosteroid sprays (INCS). In secondary care, 106 children were reviewed. Twenty-four parents completed feedback forms, all felt the parent proforma was easy to complete and helpful to their appointment. Clinician feedback was overall positive and found, “The proforma and preformatted prescription improved efficiency and allowed more consultation time to explain the technique and importance of daily use of the steroid nasal spray". In the later stages of this study, discharge rates for new patients were 78.4%.

Conclusion

This study highlights a team-based, patient centred approach to enhance the assessment and management of children with allergic rhinitis. The team created a standardized means of assessment and developed management algorithms to assist community and hospital care providers.